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Summary 
CD3 signal transducing proteins are thought to be expressed on the surface of T  cells only as 
part of clonotypic T  call receptor (TCK) complexes.  Contrary to this paradigm, the present 
study describes surface expression of CD3 proteins independently of donotypic TCR complexes, 
but only on immature thymocytes. Such novel donotype-independent CD3 (CIC) complexes 
are composed primarily of CD37e and secondarily of CD38e heterodimers that are independent 
of one another and are expressed on the cell surface in association  with an unknown 90-100 
kD protein termed CD3-associated protein (CD3AP). CIC complexes are expressed in normal 
mice on early thymocytes through the CD4+CD8 + stage of development, but not on mature 
peripheral T calls. Furthermore, CIC complexes are expressed by both TCR-  severe  combined 
immunodeficiency  (SCID) thymocytes and thymoma cell lines, in the absence of any clonotypic 
chains. The isolation and biochemical characterization of surface CIC complexes provides a structural 
basis for the signaling effects of anti-CD3e antibody treatment in early thymocyte development. 
T 
he ability of the TCR complex to transduce signals after 
specific recognition of antigen resides in the invariant 
TCR-~" and CD3  subunits (1-3).  The CD3  subunits are 
only expressed on the surface of mature T cells in association 
with clonotypic chains of the TCR complex, but this has 
not been carefully examined for thymocytes early in develop- 
ment. Immature precursor cells enter the thymus as CD4- 
CD8-TCR-  cells that are induced in the thymic microen- 
vironment to enter the CD4/CD8 developmental pathway (4). 
However,  thyrnocytes from mice that fail to rearrange the 
TCR-B gene locus fail to enter the CD4/CD8 developmental 
pathway and are arrested  at the CD4-CD8-  stage (5-10). 
This developmental arrest  can be overcome by treatment 
with anti-CD3e  mAbs which  signal  their  differentiation 
into CD4+CD8 + cells (11, 12). Treatment with anti-CD3e 
mAb has also been found to accelerate the differentiation of 
normal  CD4-CD8-  thymocytes into  CD4+CD8 +  cells 
(13). These functional data suggest that immature CD4- 
CD8-  thymocytes do express on their cell surfaces CD3 
components that are independent of donotypic TCR chains 
and that are capable of transducing signals regulating thymic 
maturation. In this study, we provide a structural explana- 
tion for the effects of anti-CD3e treatment on thymic matu- 
ration. We biochemically characterize  a surface CD3 com- 
plex composed of independent CD3ye and CD3~ heterodimers 
that are expressed separately from donotypic TCR complexes 
on early fetal thymocytes through the CD4 +  CD8 + stage of 
maturation, but that are extinguished on mature peripheral 
T  cells. Furthermore, we report that such CIC complexes 
are also expressed by TCR-  SCID thymocytes and TCR- 
thymoma lines. 
Materials and Methods 
Animals.  Young  adult C57BL/6 and CB17 sdd/scid (SCID) 
mice were obtained from the National Cancer Institute (Frederick, 
MD). FvBN fetal thymocytes, from mice at day 16 of gestation, 
were a gift of Dr. P. Love (National Institute of Child Health and 
Human Development, Bethesda, MD). 
Antibodies and Cell Lines.  Normal rabbit serum (NRS)  1 was 
obtained  from bleeds  of  rabbits maintained  in our facility. The mAbs 
used for immunoprecipitation  and iramunoblotting included: anti- 
TCK-~ (H57-597) (14), anti-TCK-c~ (H28-710) (15), anti-TCK-~$ 
(GL3) ([16]; Boehringer Mannheim Corp., Indianapolis,  IN), anti- 
CD3e (145-2Cll) (17), anti-CD3e (I-hMT3) (18), anti-CD37~ (7196) 
(19), anti-CD38 (20), and anti-TCK-~"  (551) (21). The BW5147 thy- 
morea (22) and 2B4 hybridoma (23) were maintained in RPMI 
supplemented with 10% FCS. 
1 Abbreviations used in this  ~per: CD3AP, CD3-associated  protein; CIC, 
donotype-independent  CD3; NEPHGE, nonequilibriurn  pH gradient 
electrophoresis; NRS, normal  rabbit serum; pI, isoelectric  point. 
1375  The Journal of Experimental  Medicine ￿9 Volume  180  October 1994  1375-1382 Cell Preparation and  Culture.  CD4+CD8 +  thymocytes  and 
splenic T cells from young adult C57BL/6 mice were prepared as 
described (24). Pools of thymocytes from adult CB17 scid/scid 
(SCID) mice were screened for the lack of CD4 and CD8 expres- 
sion by flow cytometry as described (25). 
Flow Cytoraetry.  106  CD4-CD8-  SCID  thymocytes  were 
washed in staining buffer (0.1% BSA and 0.1% NaN3 in HBSS 
lacking phenol red) and then treated for 1 h at 4~  with either 
staining buffer alone, 2/~g anti-CD3~ (145-2Cll),  or 2 ltg anti- 
TCR-~. After three washes in staining buffer, cells were stained 
with fluoresceinated  anti-CD3~ (145-2Cll) for 1 h at 4~  washed 
three more times, and analyzed on a FACStar Plus |  (Becton Dick- 
inson & Co., Mountain View, CA) using three decade logarithmic 
amplification. 
Radiolabelin,~ Immunoprecipitation, and Electrophoresis.  Where 
spedfied cells were treated with water soluble Bolton Hunter re- 
agent (Pierce  Chemical Co., Rockford, IL) and then iodinated with 
lactoperoxidase  as described (26-28). Bolton Hunter reagent deriva- 
tizes both lysine residues and NH2 termini of cell surface proteins 
with a structure  that can then be radiolabeled with 12sI (26). 
Surface-labded cells were extracted at 4~  using lysis buffer (1% 
digitonin/0.15  M NaC1/150 mM Tris, pH 7.4), immunoprecipi- 
tated, and electrophoresed under reducing conditions as described 
(27). Immune complexes  to be resolved  by nonequilibrium pH gra- 
dient electrophoresis (NEPHGE) were duted in NEPHGE sample 
buffer for 1 h at 37~  then resolved by NEPHGE foUowed by 
SDS-PAGE, as  described (29). Gels were fluorographed  using 
DMSO/2, 5-diphenyloxazole  (PPO) (DuPont NEN, Boston, MA) 
by incubating two times for 1 h each in DMSO, followed by 2 h 
in 20% wt/vol PPO/DMSO, and 1 h in HzO. After drying the 
gels were visualized either autoradiography at - 70~  or by phos- 
phoimagery, as indicated. 
Ricin Fractionation.  Digitonin extracts of 12sI surface-labeled 
CD4 +  CD8 + thymocytes were fractionated using ricin-Sepharose 
as described (30). Briefly, extracts were incubated with ricin beads 
for 16 h at 4~  after which the beads were washed three times 
(lysis buffer containing 0.2% digitonin) and eluted for 4 h at 4~ 
with 200 mM 13-lactose  in wash buffer containing 0.5% digitonin. 
Results 
The present study was undertaken to determine if CD3 com- 
ponents were only expressed on the surface of T cells as part 
of clonotypic TCR complexes or whether they were also ex- 
pressed on the surface of T cells independently of clonotypic 
TCR complexes. If CD3  signaling proteins were only ex- 
pressed on T  cells as components of TCR-o~/~ complexes, 
mAbs directed against CD3~  and TCR-I3 proteins should 
immunoprecipitate identical surface complexes. Consequently, 
we compared the molecular composition of surface complexes 
immunoprecipitated by anti-CD3e and anti-TCR-~ mAbs 
by SDS-PAGE  under reducing conditions (Fig.  1 A).  12sI- 
labeled surface complexes immunoprecipitated from mature 
spleen T cells by anti-CD3E and anti-TCR-13 mAbs were es- 
sentially identical. In contrast, l~I-labded surface complexes 
immunoprecipitated from immature CD4 +CD8 + thymo- 
cytes by anti-CD3E mAbs contained four to fivefold more 
labded CD33' protein than surface complexes immunopre- 
cipitated by anti-TCRq3 mAbs (Fig. 1 A). To examine these 
surface complexes with greater resolution, we analyzed anti- 
CD3~ and anti-TCR-B immunoprecipitates by two-dimen- 
sional  NEPHGE/SDS-PAGE  (Fig.  1 B).  Anti-CD3e  and 
anti-TCK-B immunoprecipitates from mature spleen T cells 
contained identical surface complexes (Fig. 1 B, righO; how- 
ever, this was not the case for immunopredpitates from im- 
mature CD4 +CD8 + thymocytes (Fig.  1 B,/eft). Anti-CD3e 
immunorecipitates from detergent extracts of CD4+CD8 + 
thymocytes not only contained all of the subunits immuno- 
precipitated by anti-TCR-~, but also contained a large amount 
of surface CD3"y protein with a basic isoelectric point (pI) 
that was not present in anti-TCR-13 immunoprecipitates and 
that was not present on spleen T cells (Fig.  1 B). This form 
of CD37, was physically independent of donotypic TCR-c~/13 
complexes on immature CD4 +  CD8 + thymocytes as it was 
captured from the supematant of anti-TCR-~ immunoprecipi- 
rations by anti-CD3~ mAb, indicating association with CD3~ 
but  not  TCR-13  chains  (Fig.  1  B,  bottom left).  Indeed, 
preclearing of donotypic TCR-c~/13 complex~ by anti-TCR-13 
mAb and sequential immunopredpitation with anti-CD3e 
mAb (Fig.  1 B, bottom left) revealed surface complexes that 
contained: (a) CD3~ chains; (b) significant amounts of CD33, 
protein with basic pI; and (c) small amounts of CD3/~; but 
did not contain donotypic TCR-a,  TCR-B,  or invariant 
TCR-~" chains. To more precisely analyze the composition 
of these TCR-independent CD3 complexes, we performed 
additional  immunopredpitation  experiments  (l~ig.  1  C). 
Clonotypic TCR complexes were first removed by immuno- 
precipitation with anti-TCR-~ mAb, and remaining surface 
CD3 subunits precipitated with antibodies specific for CD3E, 
CD33'E,  CD3/~,  and TCR-~" proteins.  Surface CD38  and 
CD33, proteins that remained after removal of donotypic TCR 
complexes existed as independent CD3ge and CD33,e het- 
erodimers that were individually immunoprecipitated by ei- 
ther anti-CD3/~ or anti-CD33,e antibodies (Fig.  1 C, right). 
Furthermore, these CD3 complexes were not associated with 
TCR-~" chains as they were not immunoprecipitated by anti- 
TCR-~" antibody (Fig.  1 C,  bottom right).  Thus, immature 
CD4+CD8 + thymocytes, but not mature spleen T cells, ex- 
press surface CD3 proteins that are not part of clonotypic 
TCR-a/13 complexes. We refer to these TCR-independent 
surface comples~ as clonotype-independent CD3 (CIC) com- 
plexes, which consist primarily of CD37E and secondarily 
of CD3~ heterodimers, and which account for 70-90%  of 
the labeled CD33, that is detected on the surface of imma- 
ture CD4 +  CD8 + thymocytes. 
It is unlikely that CIC complexes result from dissociation 
of intact TCR-c~/13 complexes by anti-TCR-B mAbs because: 
(a) appearance of CIC complexes was restricted to immature 
thymocytes and not mature T  cells, and (b) because CD33, 
chains in CIC complexes had a pI that was distinct from the 
more acidic pI of CD37' chains in clonotypic TCR-a/~ com- 
plexes. Nevertheless, we wished to detect CIC complexes on 
the surface of immature CD4 +  CD8 + thymocytes without 
anti-TCR-B immunoprecipitations. Because the basic pI of 
CD33,  chains  in  CIC  complexes  suggested incompletely 
processed N-linked sugars that lacked sialic acid and possibly 
galactose, we used an affinity matrix of the galactose-binding 
lectin Ricin communis  agglutinin (31,  32)  in an attempt to 
physically separate surface donotypic TCR-a/13 complexes 
from CIC complexes. Indeed, fractionation of cell lysates into 
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T cells,  express  CD3 complexes that  are  physically  distinct  from TCK- 
ot/fl complexes. TCIk complexes were isolated from digitonin extracts of 
Boltun  Hunter-treated  lzSI-surface-labded  immature  CD4+CD8 + 
thymocytes and mature splenic T cells, using mAbs reactive with either 
CD3e (145-2Cll) or TCR-fl. (A) More CD33, is associated with CD3e 
than with TCR-fl in immature CD4+CD8 + thymocytes. The extracts 
were immunoprecipitated  in paralld and resolved on one-dimensional SDS- 
PAGE gels. (B) CD3 that are physically distinct from the TCR-cfffl are 
expressed by immature CD4+CD8 + thymocytes. Extracts were immu- 
noprecipitated in parallel with either anti-CD3e (145-2Cll) or anti-TCR- 
fl complexes (top) or sequentially with anti-CD3e (145-2Cll) after anti- 
TCR-fl predearing (bottom). Immune complexes were resolved using two- 
dimensional (NEPHGE  x  SDS-PAGE)  gels. I2iscrimimtion  between CD38 
and CD3e proteins in these gels was accomplished by immunoblotting 
paralld gels with anti-CD35 antibody (Rg) and anti-CD3e mAb (HMT3), 
and by the differential  sensitivities  of CD38 and CD3e proteins to en- 
doglycosidase digestions. (C) CD3 compleaes  are composed as indepen- 
dent CD3~e and 3re heterodimers.  After preclearing with anti-TCR-fl, 
detergent extracts of iodinated CD4+CD8 + thymocytes were reprecipi- 
tared with either: (,,) anti-CD3e (145-2Cll); (b) anti-CD33,e (71)6);  (c) 
anti-CD35 (R.9); or (d) anti-TCR-~" (551). Positions of the TCR compo- 
nents are indicated. Arrows indicate the position of CD33r  chains  with 
a basic pl. Arrowheads indicate the position of CD3~ chains in the CIC 
comple~s. 
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face TCR-c~/~/complexes  were contained within the ricin- 
bound fraction whereas all CIC complexes were contained 
within the ricin-unbound fraction  (Fig. 2 A). The lack of 
ricin binding of CIC complexes demonstrates  that they are 
biochemically distinct from TCR-a/fl complexes expressed 
by CD4 +  CD8 + thymocytes.  Thus, these data demonstrate 
that CIC complexes are expressed on the surface of imma- 
ture CD4 +CD8 + thymocytes in a form that is physically 
distinct from the clonotypic TCR-alfl  surface complexes. 
Since the N-linked glycans of CIC complexes were imma- 
ture, we verified that the surface  labeling was indeed restricted 
to cell surface proteins  as proteins known to be exclusively 
intracellular  (i.e., ribophorin I, ribophorin II, tubulin, and 
p56  l~k) were not 12SI-labeled (data not shown). 
Since CIC complexes were physically distinct from clono- 
typic  TCR-ol/fl  complexes  on  CD4+CD8 +  thymocytes 
that expressed both complexes, we asked if CIC complexes 
could be expressed on immature thymocytes that did not ex- 
press donotypic TCR complexes. Thymocytes from SCID 
mice are unable  to productively rearrange  genes encoding 
clonotypic TCR chains  and so are arrested  at  the CD4- 
Figure 2.  The CIC complores are biochemicaUy distinct from TCR- 
c~/fl complexes. Digitonin e~tracts of Bolton Hunter-treated  12SI-sufface- 
labeled CD4 +  CD8 + thymocytes were fractionated using ricin-Sepharose. 
Both the ricin-bound  and ricin-unbound  fractions were immunoprecipi- 
tated with anti-CD3e (145-2Cll), after which the immune  complexes  were 
resolved on two-dimensional gels (NEPHGE  x  SDS-PAGE). Positions 
of TCR components are indicated. The position of the basic form of  CD3"y 
is indicated by arrows. The migration of CD3c5 is indicated by arrowheads. 
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CD8  -  TCR-  stage of development (5-8). We asked if these 
TCR-  SCID thymocytes expressed CIC complexes. Flow 
cytometric analysis of SCID thymocytes revealed a very low 
level of surface CD3e protein whose staining could be spe- 
cifically blocked by unlabeled  anti-CD3e mAb, but not by 
unlabeled anti-TCR-fl mAb (Fig. 3 A), demonstrating that 
immature SCID thymocytes do express low levels of surface 
CIC complexes. To investigate the composition of the CD3 
complexes expressed by the SCID thymocytes, surface-labeled 
SCID thymocytes were analyzed by immunoprecipitation. 
Consistent with the absence of donotypic TCR complexes, 
anti-TCR-fl mAb failed to specifically  immunoprecipitate any 
surface labeled proteins  from SCID thymocytes  (Fig. 3 B, 
left). The faint bands that were present in some SCID anti- 
TCR-B immunoprecipitations were also nonspecitically pre- 
cipitated by NKS (Fig. 3 B,/eft). Interestingly, however, im- 
munoprecipitation of surface labeled proteins with anti-CD3e 
mAb revealed CIC complexes on the surface of TCR- SCID 
thymocytes that included CD3%6, and e chains. The pres- 
ence of both CD36 and CD3e proteins  in the 25-kD band 
of experiment 2 (Fig. 3 B,/eft) was confirmed by NEPHGE 
analysis (data not shown). In addition to these CD3 compo- 
nents,  we also observed an unknown associated protein of 
90-100  kD  that  we have termed CD3-associated  protein 
(CD3AP). CD3AP contains no N-linked glycam (data not 
shown) and its further characterization  is currently in prog- 
ress. We then examined early (day 16) fetal thymocytes from 
normal mice for surface expression of CIC complexes. Al- 
though these early fetal thymocytes expressed little if any sur- 
face TCR-fl proteins, sequential anti-CD3e immunoprecipi- 
tations detected both CIC and donotypic TCR-7//~ complexes 
(Fig. 3 B, right). CIC surface complexes on fetal thymocytes 
could be isolated independently from donotypic TCR-3,/6 
surface complexes by preclearing cell lysates with anti-TCR- 
/~ and anti-TCR-fl mAbs, followed by sequential immuno- 
precipitation  with anti-CD3e mAb (Fig. 3 B, right). Thus, 
CIC complexes including CD3AP are expressed on the sur- 
face of both TCR- SCID thymocytes and normal fetal thy- 
mocytes. 
To further evaluate expression of CIC surface complexes 
on immature TCR-  thymocytes,  we examined the imma- 
ture TCR-  thymoma line BW5147.  BW5147 cells did ex- 
press surface CIC complexes consisting  of CD3%  e, and 
CD3AP (Fig. 4,  top left). The absence of CD3# in surface 
CIC compleaes on BW5147 cells reflects the absence of CD3/~ 
protein expression in the BW5147 subline used (22). Impor- 
tantly,  because  this BW5147  subline  also fails to  express 
TCR-fl, the TCR-cr chains remain unassembled within the 
endoplasmic reticulum and are not transported to the cell 
surface (data not shown). Indeed, significant amounts of in- 
tracellular TCR-c~ protein are present in BW5147  cells as 
demonstrated by protein immunoblots (Fig. 4, bottom). De- 
spite the presence  of a large intracelhlar pool of TCK-c~ chains, 
none of the TCR-cr  became iodinated during the surface 
labeling procedure (Fig. 4, top left). Taken together, these data 
demonstrate that  12SI-labeled CIC complexes were on the 
surface and were not internal protein complexes that had be- 
come 12SI-labeled at some point during the coupling reac- 
Expression of Clonotype-independent CD3 Complexes on Immature Thymocytes Figure  3.  CIC complexes are  ex- 
pressed by TCR-  SCID thymocytes 
and  normal fetal tbymocytes. (A) 
TCR- SCID thymocytes  express low 
levels of CD3. CD4-CD8-  tbymo- 
cytes from CB17 sdd/scid mice were 
stained  with fluorcsceinated  anti-CD3e 
(145-2Cll) after  pretreatment  with ei- 
ther staining  medium,  unlabeled  anti- 
CD3e (145-2Cll), or unlabeled anti- 
TCR-/~. (B) CIC complexgs are ex- 
pressed by TCR-  immature thymo- 
cytes. Digitonin extracts of Bolton 
Hunter-treated  12SI-surface-labeled 
SCID thymocytes  and fetal  thymocytes 
were immunoprecipitated  sequentially 
with  the  indicated mAbs and  the 
resulting immune  complexes resolved 
by SDS-PAGE under reducing  condi- 
tions. The anti-CD3e mAb used was 
145-2Cll. Positions of TCK compo- 
nents are indicated. 
tion, and are consistent with the detection of isolated CD3 
complexes on another thymoma cell line (33). Interestingly, 
even though we detected CIC complexes  on BW5147 thy- 
moma cells, we could not detect CIC complexes on the ma- 
ture T cell hybridoma 2B4 that had been generated by fusion 
of a mature T cell with BW5147 thymoma cells (Fig. 4, top 
right).  Thus, CIC complexes are expressed by an immature 
TCR-  thymoma cell line but not expressed  by a mature 
TCR + T cell hybridoma, mimicking the differential in vivo 
appearance of CIC complexes on immature thymocytes but 
not mature T  cells. 
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Discussion 
The present results demonstrate that immature thymocytes, 
but not mature T calls, express CD3 proteins independently 
of the clonotypic TCR complexes.  CIC complexes consist 
primarily of CD33,e and secondarily of CD36e heterodimers 
that are both physically and biochemically distinct from the 
CD3 chains that are part of clonotypic TCR complexes.  In 
addition to CD3%6, and E proteins, CIC complexes are as- 
sociated with an unknown surface protein termed CD3AP. 
CIC complexes may also contain other components that have Figure 4.  Expression  of CIC complexes  is developmentally  regulated. 
Detergent  extracts  of 125I-surface-labeled  BW5147  thymoma  and 2B4 hy- 
bridoma cells were  immunoprecipitated  sequentially  with the indicated 
antibodies  (top).  Digitonin  lysates  of unlabeled  BW5147 thymoma  cells 
were resolved  by SDS-PAGE  and immunoblotted  with anti-TCR-c~  and 
anti-CD3e (HMT3) antibodies.  Positions  of the TCR components  are in- 
dicated. 
not yet been identified. However, it is dear that CIC com- 
plexes are devoid of TCR-~ chains and so are distinct from 
TCR-B-X dimeric complem~s  that have recently been described 
on immature thymocytes (7,  34). 
The biochemical characterization of CIC complexes that 
are expressed on the surface of immature thymocytes  required 
the  direct  analysis  of surface-labeled  membrane proteins. 
Previous attempts using metabolic labeling to analyze the struc- 
ture of surface TCR complexes in immature thymocytes  must 
necessarily be uninformative as metabolic labeling identifies 
newly synthesized proteins that may or may not be eventu- 
ally expressed on the cell surface (10).  This is a particular 
limitation of metabolic labeling experiments for examination 
of partial TCR complexes (10) that are largely, if not com- 
pletely, retained intracellularly and not transported to the cell 
surface (1). In the present study, we exclusively used surface 
labeling procedures to identify CIC complexes; nevertheless, 
the observed immaturity of their N-linked glycans suggested 
that they had not been processed by glycosidases resident in 
the Golgi apparatus (31, 32) and so might not really have 
been expressed on the cell surface. Consequently, it was im- 
portant to exclude the possibility that internal protein com- 
plexes had been artefactually labeled during the surface hbeling 
reaction. In fact,  we verified that the surface labeling was 
selective for cell surface proteins by looking for labeling of 
proteins known to be exclusively internal. No labeling of 
ribophorin I, ribophorin II, tubulin, or p56  Id~ was observed 
in CD4+CD8 + thymocytes, nor did we observe any labeling 
of the abundant internal TCK-c~ chains expressed by BW5147 
thymoma cells. Finally,  we directly demonstrated by flow 
cytometry the presence of low levels of CD3e expressed on 
the surface of SCID tbymocytes. It is important to empha- 
size that a precedent exists for expression by immature thymo- 
cytes of proteins bearing incompletely processed  N-linked 
glycans. For example, TCK-/~ chains existing as TCK-B-X 
heterodimers on the surface of immature tbymocytes possess 
incompletely processed N-linked glycans (7, 34).  The mo- 
lecular explanation for this incomplete processing of sugars 
is unclear,  but may be related  to an inability of immature 
thymocytes to efficiently retain incompletely  assembled TCK 
complexes within the endoplasmic reticulum. 
Identification  of CIC complexes on immature TCR- thy- 
mocytes provides a structural basis for signaling in early thymo- 
cytes independently of clonotypic TCR complexes and pro- 
vides a molecular basis for studies indicating functional effects 
of anti-CD3e mAb on early thymocyte development (11-13). 
It is undear why CIC complexes consist overwhelmingly  of 
CD3ye, rather than CD3~e, compka~s, but the predominance 
of CD3"ye complexes has  also been observed in RAG-1- 
thymocytes (12). The present results demonstrate that TCR- 
early  tbymocytes express on their surfaces CIC complexes 
composed of proteins with the capability of transducing in- 
tracellular signals upon ligation by anti-CD3e mAb (35). Thus, 
we think that CIC complexes are responsible for the ability 
of anti-CD3e stimulation to promote the differentiation of 
CD4-CD8-TCR-SCID  and  RAG-l-  thymocytes  into 
CD4+CD8 + cells (11, 12). In addition, we think that CIC 
complexes on early TCR-  tbymocytes might play a role in 
inducing maturation of the thymic microenvironment (36). 
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